The marketer of brain health supplement Prevagen agrees in a proposed settlement to seven class actions not to make “improves memory” claims without “competent and reliable scientific evidence as substantiation," or to "conspicuously" qualify the basis for the claims.
[Quincy Bioscience LLC] doesn’t admit to “any liability or wrongdoing of any kind associated with the claims alleged” in the proceedings in US District Court for Southern Florida, but agrees to pay the plaintiffs in the certified class cash refunds of 30% of the
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?